PacBio to Report Third Quarter 2023 Financial Results on October 30, 2023


Werte in diesem Artikel

MENLO PARK, Calif., Oct. 12, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2023 financial results on Monday, October 30, 2023, at 4:30 pm Eastern Time.

(PRNewsfoto/Pacific Biosciences of California, Inc.)

The call will be webcast and may be accessed at PacBio's website at: https://investor.pacificbiosciences.com/.

Date: Monday, October 30, 2023, at 4:30 pm ET (1:30 pm PT)
Listen live via internet or replay: https://investor.pacificbiosciences.com/
Toll-free: 1-888-349-0136
International: 1-412-317-0459

If using the dial-in option, please dial into the call ten minutes prior to start time using the appropriate number above and ask to join the "PacBio Q3 Earnings Call."

About PacBio

Pacific Biosciences of California, Inc. is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing and our emerging SBB® short read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information please visit www.pacb.com and follow @PacBio.

Contacts

Investors:
Todd Friedman
650.521.8450
ir@pacb.com 

Media:
Lizelda Lopez
pr@pacb.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/pacbio-to-report-third-quarter-2023-financial-results-on-october-30-2023-301955273.html

SOURCE Pacific Biosciences of California, Inc.

Aktuelle Pacific Biosciences of California Aktie News

Werbung

Pacific Biosciences of California Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Pacific Biosciences of California nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
Datum Rating Analyst
19.10.18 Pacific Biosciences of California Outperform Cowen and Company, LLC
03.11.17 Pacific Biosciences of California Equal-Weight First Analysis Securities
03.11.16 Pacific Biosciences of California Buy Cantor Fitzgerald
15.04.16 Pacific Biosciences of California Overweight First Analysis Securities
04.02.15 Pacific Biosciences of California Buy Maxim Group

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.